Also visit: ThrillOf
 

Elsewhere on HealthThreads: Stomach cancer | Overactive bladder | Lymphoma | Thyroid cancer |

Men's Health Month: Recognize Your Individual Risk for Bladder Cancer external link

UroToday | Thu, Jun 4

UroToday is the #1 News Source for Bladder cancer

 CA
One of the first signs is blood in the urine (hematuria). Other signs can include painful urination, increased frequency of urination, a feeling of needing to urinate but not being able to do so, and chronic bladder inflammation from recurrent urinary ...

[Read original...]

Try These Related Topics

 

More UroToday

SUO 2009 - Recent advances in bladder cancer: Pros and cons of adjuvant versus ...

Postoperative nomogram for invasive bladder cancer: Does it really work? A ...

SUO 2009 - Bladder Cancer I: Emerging technology - How will this affect ...

Associations Between Comorbidity, and Overall Survival and Bladder ...

Strategies for molecular expression profiling in bladder cancer - Abstract

The role of bacillus Calmette-Guérin in the treatment of non-muscle-invasive ...

Management of the First Recurrence of T1G3 Bladder Cancer: Does ...

A Population Based Assessment of Perioperative Mortality After ...

Efficacy of Bacille Calmette-Guérin Immunotherapy Predicted by ...

Bladder Cancer Screening in a High Risk Asymptomatic Population ...

An Individual Patient Data Meta-Analysis of the Long-Term Outcome ...

Patterns of Use of Systemic Chemotherapy for Medicare ...

Bladder Cancer Clusters in Florida: Identifying Populations at ...

Imaging and Staging of Transitional Cell Carcinoma: Part 1, Lower ...

Inter-Observer Variability of Clinical Target Volume Delineation ...

Detection of Urothelial Bladder Cancer Cells in Voided Urine Can ...

SUO 2009 - Assessing the clinical benefit of NMP22 in the surveillance of ...

Secondhand Smoking, 4-Aminobiphenyl, and Bladder Cancer: Two Meta ...

Hexylaminolevulinate Photodynamic Diagnosis for Multifocal ...

A Lower Risk of Dying from Urological Cancer in Down Syndrome ...

Tumor Detection and Serosal Invasion of Bladder Cancer: Role of ...

Twenty-Year Experience of Radical Cystectomy for Bladder Cancer in ...

Impact of Treatment Delay in Patients with Bladder Cancer Managed ...

Menthol induces cell death via the TRPM8 channel in the human bladder cancer ...

Comparing the safety and efficiency of conventional monopolar, plasmakinetic ...

ASCO 2009 - Ethnic Differences in Bladder Cancer Survival ...

Role of pelvic lymph node dissection in lymph node-negative patients with ...

Current status of robot-assisted radical cystectomy - Abstract

Are patients with non-muscle-invasive bladder cancer a suitable population for ...

SUO 2009 - DNA methylation - Session Highlights

Urinary diversion and morbidity after radical cystectomy for bladder cancer ...

Differential Effects of MAPKs Signaling on the Growth of Invasive ...

Expression of cell cycle-associated proteins in non-muscle-invasive bladder ...

Fluorescence-guided laser therapy for penile carcinoma and precancerous ...

Long-term clinical outcomes of a phase I trial of intravesical docetaxel in ...

Bikunin loss in urine as useful marker for bladder carcinoma - Abstract

Clinical implications and prognostic values of topoisomerase-II alpha ...

The aggressiveness of urothelial carcinoma depends to a large extent on ...

Related News

Top Bloggers

Related Photos

Opinion: Indevus Pharmaceuticals: Valstar reintroduced into bladder cancer ...

Thumbnail SYS-CON Media (press release) There is a high unmet need in the treatment of recurrent CIS bladder tumors because, generally, they do not respond well to chemotherapy. BCG immunotherapy shows the best efficacy against recurrent CIS bladder tumors, but patients often show poor ...
Thu, Mar 19 |  from drugdiscovery.pharmaceutical-business-review.com

 

Related Videos

 
 

Do you publish a blog? If so, consider joining the Boxxet Network and see your great content showcased and rewarded! Learn more...

©2009 Boxxet, Inc. | Contact | Privacy Policy | Terms of Service
Page updated Thu, Dec 31.